Publications
- Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
- Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
- Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib2016 | Faculty of Medicine in Pilsen, Faculty of Science
- The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study2015 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis2014 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer2013 | Faculty of Medicine in Pilsen
- Gene Mutations in Squamous Cell NSCLC: Insignificance of EGFR, KRAS and PIK3CA Mutations in Prediction of EGFR-TKI Treatment Efficacy2013 | Faculty of Medicine in Pilsen
- Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC2013 | Faculty of Medicine in Pilsen
- Second-line treatment of advanced NSCLC: Comparison of efficacy of erlotinib and chemotherapy2013 | Faculty of Medicine in Pilsen
- EGFR mutations in patients with advanced NSCLC2012 | Faculty of Medicine in Pilsen
Loading network view...
